The number of new active substances launched in 2015 fell by nearly a third compared with the previous year. But there is no need for despair – beating 2014's record-breaking year of 63 new active substance (NAS) launches was always going to be a tall order, and 2015's tally actually came in at a very respectable 46.
AbbVie Inc. just won approval to market a drug to compete with, well, one of its own medicines, sort of.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.